Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period
2014 · Annals of the Rheumatic Diseases · 232 citations
https://doi.org/10.1136/annrheumdis-2014-206106